Heron Pharmaceutical

Nanjing, China · Founded 2013 · Privately Held (backing)

Developer and provider of pharmaceutical R&D services and specialty drug development solutions designed for the discovery and optimization of innovative, modified, and generic medicines. Heron Pharmaceutical is based in Nanjing, China and was founded in 2013. Its last reported valuation was $378 million in Dec 2025. It has raised $46.2 million.

Last reported valuation
$377.9M
Oct 2026
Priced at
—
Total raised
$46.2M
Last round
—

Who backs Heron Pharmaceutical?

5 investors
InvestorType
DPH CapitalHedge fund
Guosheng Capital—
SUNNOVO—
Tibet Dorui Pharmaceutical—
Xi'an Manareco—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Heron Pharmaceutical investors

5 investors are on record for Heron Pharmaceutical, including DPH Capital, Guosheng Capital, SUNNOVO and Tibet Dorui Pharmaceutical.

Free account
More of Heron Pharmaceutical with a free account
  • ·Watch Heron Pharmaceutical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Heron Pharmaceutical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View